Xuefei Wang

ORCID: 0000-0003-3268-3152 · 2 papers in corpus
review 2026
Pharmaceutics ·doi:10.3390/pharmaceutics18091134

Background: Polydatin has shown anti-inflammatory, antioxidant, and cytoprotective effects in preclinical studies. Its development is limited by low oral bioavailability, extensive metabolism, and poorly defined tissue exposure. Objectives:…

other 2022
Frontiers in medicine ·doi:10.3389/fmed.2022.969724

BACKGROUND: Adenomyosis is a common gynecological disease in women. A relevant literature search found that approximately 82% of patients with adenomyosis chose to undergo hysterectomy. However, women of childbearing age are more likely to …